Imane Bourhafour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Imane Bourhafour has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hanan Elkacemi
Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
2 shared publications - Meryem Benoulaid
Department of Radiotherapy, National Institute of Oncology, Mohammed V University, Rabat, Morocco.
2 shared publications - Sanaa Elmajjaoui
Immunopathology-Immunotherapy-Immunomonitoring Laboratory, Faculty of Medicine, Mohammed VI University of Health and Sciences (UM6SS), Casablanca 82403, Morocco
2 shared publications - Tayeb Kebdani
Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
2 shared publications - Basma Khannoussi
Department of Pathology, National Institute of Oncology, Mohammed V University, Rabat, Morocco
1 shared publication - Jihane Khalil
Radiation oncology department, National Institute of oncology, Mohamed V University, Rabat, Morocco
1 shared publication
Latest Publications
- Open Access
- 23 September 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 265
Skin metastases of cervical cancer: two case reports and review of the literature
Although cervix carcinoma is one of the most common malignancies in women, hematogenous metastases are relatively not common. Cutaneous metastases, in particular, are unusual even at an advanced stage of disease. Their presence is a predictor of poor prognosis. Case 1: A 63-year-old postmenopausal Moroccan woman was diagnosed as having cervical squamous cell carcinoma. She was treated with radical concurrent chemotherapy and radiation therapy followed by low-dose brachytherapy. Six months after finishing the therapy, multiple skin nodules appeared on her abdomen and chest wall. An excision biopsy was performed and showed metastatic squamous cell carcinoma. Her disease progressed and she died before completing her fourth course of palliative chemotherapy. Case 2: A 48-year-old Moroccan woman was diagnosed as having cervical squamous cell carcinoma; she was treated with concurrent chemoradiation. Before a planned high-dose brachytherapy, she noticed many nodular lesions on her arms, thighs, and chest wall. An excision biopsy was performed and showed metastatic squamous cell carcinoma. She then underwent a series of imaging examinations, including computed tomography of her chest, abdomen, and pelvis, and a whole body bone scan that showed disseminated disease involving her lungs and bones. She died after two courses of palliative chemotherapy, 2 months after the appearance of the skin lesions. We report two cases to illustrate a rare localization of metastasis from cervical carcinoma that is highly aggressive requiring early detection and aggressive management.
- 23 September 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 265
Open AccessSkin metastases of cervical cancer: two case reports and review of the literature
Although cervix carcinoma is one of the most common malignancies in women, hematogenous metastases are relatively not common. Cutaneous metastases, in particular, are unusual even at an advanced stage of disease. Their presence is a predictor of poor prognosis. Case 1: A 63-year-old postmenopausal Moroccan woman was diagnosed as having cervical squamous cell carcinoma. She was treated with radical concurrent chemotherapy and radiation therapy followed by low-dose brachytherapy. Six months after finishing the therapy, multiple skin nodules appeared on her abdomen and chest wall. An excision biopsy was performed and showed metastatic squamous cell carcinoma. Her disease progressed and she died before completing her fourth course of palliative chemotherapy. Case 2: A 48-year-old Moroccan woman was diagnosed as having cervical squamous cell carcinoma; she was treated with concurrent chemoradiation. Before a planned high-dose brachytherapy, she noticed many nodular lesions on her arms, thighs, and chest wall. An excision biopsy was performed and showed metastatic squamous cell carcinoma. She then underwent a series of imaging examinations, including computed tomography of her chest, abdomen, and pelvis, and a whole body bone scan that showed disseminated disease involving her lungs and bones. She died after two courses of palliative chemotherapy, 2 months after the appearance of the skin lesions. We report two cases to illustrate a rare localization of metastasis from cervical carcinoma that is highly aggressive requiring early detection and aggressive management.
- Open Access
- 1 May 2015
- Published by Springer Nature in Gynecologic Oncology Research and Practice
- Vol. 2 (1) , 1-4
Lumbosacral plexopathy: A rare long term complication of concomitant chemo-radiation for cervical cancer
Radiation induced Lumbosacral plexophaty (RILP) is a rare but severe complication that has a considerable impact on quality of life. Its occurrence is rare but increasing with improved long-term cancer survival. This entity commonly results in different degrees of sensory and motor deficits. The pathophysiological mechanisms are not yet fully understood. Diagnosis of radiation myelopathy in women with gynecologic malignancies may increase with the use of concomitant chemo-radiation. This report describes the effect of this combination therapy in a 64-year-old woman with cervical carcinoma.
- 1 May 2015
- Published by Springer Nature in Gynecologic Oncology Research and Practice
- Vol. 2 (1) , 1-4
Open AccessLumbosacral plexopathy: A rare long term complication of concomitant chemo-radiation for cervical cancer
Radiation induced Lumbosacral plexophaty (RILP) is a rare but severe complication that has a considerable impact on quality of life. Its occurrence is rare but increasing with improved long-term cancer survival. This entity commonly results in different degrees of sensory and motor deficits. The pathophysiological mechanisms are not yet fully understood. Diagnosis of radiation myelopathy in women with gynecologic malignancies may increase with the use of concomitant chemo-radiation. This report describes the effect of this combination therapy in a 64-year-old woman with cervical carcinoma.